LEPU ScienTech Medical Technology (HKG:2291) resumed trading on the Hong Kong bourse Wednesday after halting trading of its shares Tuesday following price share fluctuations.
The medical device company attributed the share movement to investor recognition of its "continuous" results and performance growth, as well as the restoration of its value, according to a same-day filing with the Hong Kong bourse.
LEPU ScienTech forecast a 30% rise in its sales target for its occluder product and 200 million yuan sales for its transcatheter aortic valve replacement product, the filing said.
LEPU ScienTech suspended trading Tuesday morning at 10:57 a.m. and closed at HK$23.55. It resumed trading Wednesday morning, opening 8% higher at HK$25.50.
Shares plunged 14% during afternoon trading on Wednesday.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。